NASDAQ: CING
Cingulate Inc Stock Ownership - Who owns Cingulate?

Insider buying vs selling

Have Cingulate Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Thomas Jeffrey HargrovesDirector2026-02-1397,276$5.04
$490.27kBuy
Matthew BramsEVP and Chief Medical Officer2026-02-061,946$5.04
$9.81kBuy
Jennifer L. CallahanSVP and CFO2026-02-064,864$5.04
$24.51kBuy
Shane J. SchafferChief Executive Officer2026-02-066,809$5.04
$34.32kBuy
Peter J. WerthDirector2026-02-0619,455$5.04
$98.05kBuy

1 of 1

CING insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CING insiders and whales buy or sell their stock.

CING Shareholders

What type of owners hold Cingulate Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Werth Family Investment Associates LLC18.70%2,798,320$13.21MInsider
Fountainhead Shrugged LLC5.40%807,828$3.81MInsider
Craig S. Gilgallon1.30%194,846$919.67kInsider
Gregg Wm Givens1.16%174,318$822.78kInsider
Horn Louis G. Van1.05%156,606$739.18kInsider
Peter J. Werth0.79%117,541$554.79kInsider
Patrick Joseph Gallagher0.46%68,358$322.65kInsider
Shane J. Schaffer0.10%14,251$67.26kInsider
Jennifer L. Callahan0.09%13,961$65.90kInsider
Thomas Jeffrey Hargroves0.06%8,492$40.08kInsider

1 of 3

CING vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CING0.02%29.24%Net Buying
COYA0.03%9.20%
VTVT0.00%100.00%
MNOV0.02%84.05%Net SellingNet Selling
AVXL0.04%4.79%

Cingulate Stock Ownership FAQ

Who owns Cingulate?

Cingulate (NASDAQ: CING) is owned by 0.02% institutional shareholders, 29.24% Cingulate insiders, and 70.74% retail investors. Werth Family Investment Associates LLC is the largest individual Cingulate shareholder, owning 2.80M shares representing 18.70% of the company. Werth Family Investment Associates LLC's Cingulate shares are currently valued at $13.21M.

If you're new to stock investing, here's how to buy Cingulate stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.